Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2026-01-01 @ 8:15 PM
Study NCT ID:
NCT04935359
Status:
COMPLETED
Last Update Posted:
2025-01-07
First Post:
2021-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-21
First Submit QC Date:
None
Study First Post Date:
2021-06-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-06
Last Update Post Date:
2025-01-07
Last Update Post Date Type:
ACTUAL